PubRank

P O Attman

Author PubWeight™ 32.91‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Apolipoprotein-B-containing lipoproteins and the progression of renal insufficiency. Nephron 1993 1.42
2 Hyperlipoproteinaemia in renal failure: pathogenesis and perspectives for intervention. Nephrol Dial Transplant 1993 1.41
3 Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency. Nephrol Dial Transplant 1997 1.33
4 Lipoprotein abnormalities without hyperlipidaemia in moderate renal insufficiency. Nephrol Dial Transplant 1994 1.17
5 Pharmacokinetic and pharmacodynamic properties of metoprolol in patients with impaired renal function. Clin Pharmacokinet 1980 1.13
6 Expert working group report on nutrition in adult patients with renal insufficiency (Part 2 of 2). Clin Nutr 2000 0.97
7 Complex apolipoprotein B-containing lipoprotein particles are associated with a higher rate of progression of human chronic renal insufficiency. J Am Soc Nephrol 1998 0.92
8 Diabetic nephropathy: is dietary protein harmful? J Diabet Complications 1988 0.92
9 Cadmium, mercury, and lead in kidney cortex of the general Swedish population: a study of biopsies from living kidney donors. Environ Health Perspect 1999 0.89
10 Expert Working Group report on nutrition in adult patients with renal insufficiency (part 1 of 2). Clin Nutr 2000 0.88
11 Renal hemodynamics and limitations of creatinine clearance in determining filtration rate in glomerular disease. Scand J Urol Nephrol 1971 0.87
12 Effects of metoprolol and propranolol on furosemide-stimulated renin release in healthy subjects. Eur J Clin Pharmacol 1975 0.87
13 Dyslipidemia in peritoneal dialysis--relation to dialytic variables. Perit Dial Int 2000 0.84
14 Angiotensin I-converting enzyme gene polymorphism in non-diabetic renal disease. Nephrol Dial Transplant 2000 0.83
15 Left ventricular function before and after kidney transplantation. A prospective study in patients with juvenile-onset diabetes mellitus. Eur Heart J 1986 0.82
16 Extracorporeal ("ex vivo") connection of pig kidneys to humans. I. Clinical data and studies of platelet destruction. Xenotransplantation 1996 0.80
17 Determination of glomerular filtration rate in advanced renal insufficiency. Scand J Urol Nephrol 1978 0.80
18 Apolipoprotein C-III, hypertriglyceridemia and triglyceride-rich lipoproteins in uremia. Miner Electrolyte Metab 2000 0.80
19 Body composition in patients treated with peritoneal dialysis. Nephrol Dial Transplant 1998 0.80
20 Long-term treatment with low protein diet in uremia. Contrib Nephrol 1986 0.79
21 Nitrogen balance studies in patients with uremia during treatment with protein-reduced diet and supplementation with essential amino acids or keto acids. Ann Nutr Metab 1984 0.79
22 Experience of immunosuppressive therapy of glomerular disease in adults. Acta Med Scand 1971 0.79
23 Survival in end-stage diabetic renal disease. A prospective study of 100 kidney transplant patients. Acta Med Scand 1984 0.78
24 Heparin-induced thrombocytopenia during continuous haemofiltration. Nephrol Dial Transplant 1995 0.78
25 Creatinine generation rate and lean body mass: a critical analysis in peritoneal dialysis patients. Kidney Int 1997 0.78
26 An antigenic relationship between human kidney, colon and the common antigen of enterobacteriaceae. Int Arch Allergy Appl Immunol 1972 0.78
27 Limitations in anthropometric calculations of total body water in patients on peritoneal dialysis. J Am Soc Nephrol 2001 0.78
28 Protein-reduced diet in diabetic renal failure. Clin Nephrol 1983 0.78
29 Survival of patients on hemodialysis after renal graft failure. Acta Med Scand 1975 0.77
30 Urea kinetics during hemodialysis measured by microdialysis--a novel technique. Kidney Int 1993 0.77
31 Progression of renal failure and lipids--is there evidence for a link in humans? Nephrol Dial Transplant 1998 0.77
32 Plasma levels of lipoprotein (a) do not predict progression of human chronic renal failure. Nephrol Dial Transplant 1996 0.76
33 Dimensions of arteriovenous fistulas in patients with autosomal dominant polycystic kidney disease. Nephron 2000 0.76
34 Is smoking a risk factor for progression of chronic renal failure? Kidney Int 2000 0.76
35 The plasma levels of homocysteine are elevated in moderate renal insufficiency but do not predict the rate of progression. Nephron 1999 0.76
36 Proteinuria and renal function in kidney transplant donors 10-18 years after donor uninephrectomy. Ups J Med Sci 1985 0.76
37 Dual PPAR α / γ Agonism Normalizes Lipoprotein Profile of Renal Dyslipidemia. PPAR Res 2013 0.75
38 Pharmacokinetics of felodipine in patients with impaired renal function. Br J Clin Pharmacol 1989 0.75
39 Do high-flux dialysis membranes affect renal dyslipidemia? ASAIO J 2001 0.75
40 [Indications for treatment with low-protein diet and essential amino acids in uremia]. Lakartidningen 1975 0.75
41 Lipoprotein particles in hypertriglyceridemic states. Adv Exp Med Biol 1988 0.75
42 Left ventricular function before and after renal transplantation in diabetics. Transplant Proc 1984 0.75
43 Conflicting results between glomerular filtration rate and serum creatinine measurements in chronic renal failure. Contrib Nephrol 1986 0.75
44 Body composition in renal failure and the effect of dialysis. Appl Radiat Isot 1998 0.75
45 Effect of gemfibrozil on lipoprotein abnormalities in chronic renal insufficiency: a controlled study in human chronic renal disease. Nephron 1997 0.75
46 Graft survival and blood transfusion. Proc Eur Dial Transplant Assoc 1977 0.75
47 Nitrogen balance studies with amino acid supplemented low-protein diet in uremia. Am J Clin Nutr 1979 0.75
48 [Experience with high doses of furosemide in advanced renal insuffiency]. Lakartidningen 1971 0.75
49 Prognostic impact of ACE inhibition in systemic lupus erythematosus, diabetes mellitus and chronic glomerulonephritis. Contrib Nephrol 1990 0.75
50 [Hemodialysis cured severe lactic acidosis caused by metformin treatment]. Lakartidningen 1999 0.75
51 Improved clearance of iohexol with longer haemodialysis despite similar Kt/V for urea. Nephrol Dial Transplant 1999 0.75
52 [Treatment of SLE-nephritis: literature review]. Lakartidningen 1978 0.75
53 Time as a risk factor in diabetic nephropathy. Diabetes Care 1986 0.75
54 Effect of protein-reduced diet on plasma lipids, apolipoproteins and lipolytic activities in patients with chronic renal failure. Am J Nephrol 1984 0.75
55 Apolipoprotein pattern in patients with chronic renal failure. Contrib Nephrol 1984 0.75
56 [Immunosuppressive treatment of glomerulonephritis]. Lakartidningen 1975 0.75
57 Acute renal insufficiency after administration of low-osmolar contrast media. Lancet 1986 0.75
58 Lipid and carbohydrate metabolism in uraemia. Eur J Clin Invest 1979 0.75
59 Body composition during long-term treatment of uremia with amino acid supplemented low-protein diet. Am J Clin Nutr 1980 0.75
60 First clinical experience with a new concentrate system for dialysis with dry sodium chloride. ASAIO J 1999 0.75
61 Long-term outcome of renal function and proteinuria in kidney transplant donors. Proc Eur Dial Transplant Assoc Eur Ren Assoc 1985 0.75
62 Characterization of the anti-A antibody binding in an ABO-incompatible living donor renal transplantation. Nephrol Dial Transplant 1994 0.75
63 [Diagnosis, therapy and follow-up of patients with SLE]. Lakartidningen 1978 0.75
64 Glomerular filtration rate, hypertension and proteinuria after renal ablation: a long-term follow-up study in kidney donors. Scand J Urol Nephrol Suppl 1988 0.75
65 [SLE in Gotenburg 1966-74]. Lakartidningen 1978 0.75
66 Growth during treatment with low-protein diet in children with renal failure. Clin Nephrol 1984 0.75
67 Lipid and carbohydrate metabolism in uremia. Influence of treatment with protein-reduced diet and essential amino acids. Nutr Metab 1980 0.75
68 Increase of calcitriol during treatment with protein-reduced diet in patients with renal failure. Nephron 1994 0.75
69 Morbidity and mortality in diabetic and non-diabetic recipients of living related donor kidneys. Nephrol Dial Transplant 1987 0.75